TrialLancet (London, England)2008

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.

Reinhard G Bretzel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.